Cocaine-Induced Plasma Cell Dermatomucositis (CI-PCDM): Clinical and Histopathological Features of a UK Cohort Authors: Grigorios Thermos, Emily Morrison, Laura Cuddy, Waseem Ghumra, Konstantinos Paraschou, Catherine Brophy, Arun Takhar, Theofano Tikka, Paris Tamiolakis, Nitin Khirwadkar Published: 2026 ABSTRACT AbstractBackgroundCocaine-induced plasma cell dermatomucositis (CI-PCDM) is an emerging clinical entity involving ulcerated, nodular lesions of the nasolabial region. While it shares some clinical features with other cocaine-induced midline disorders, CI-PCDM is increasingly recognized as a distinct inflammatory process characterized by specific histological patterns.MethodsThis retrospective, multi-center case series identified six patients from two UK pathology archives. Data were retrieved from electronic records and medical photography, while histopathology and immunohistochemistry reports were reviewed to evaluate diagnostic features and exclude alternative pathologies.ResultsThe cohort consisted of five males and one female (mean age 50.3 years). Patients typically presented with exophytic, ulcerated masses in the nasolabial area. Cocaine exposure was confirmed in all cases through clinical history or toxicology. Histology consistently revealed dense, polyclonal plasmacytic infiltrates in perivascular and periadnexal distributions. Serological and immunohistochemical variations were noted, including instances of antibody positivity and altered protein ratios. Management strategies, including medical and surgical interventions, generally resulted in partial clinical improvement.ConclusionThis first UK-based case series highlights CI-PCDM as an emerging diagnostic challenge. The prominent cellular infiltrate may reflect a chronic, antigen-driven immune response, potentially related to localized cytokine activity triggered by cocaine and/or certain adulterants, such as benzocaine. The clinical presentation often mimics other common mucocutaneous lesions, necessitating thorough clinicopathological correlation. Increased clinical awareness is essential for accurate identification and for establishing optimal management protocols for affected patients.Keywords: Cocaine, Plasma cells, Mucositis, Dermatitis, Levamisole, IgG4 Introduction Once employed in clinical practice as a topical anesthetic derived from coca plant species, cocaine exerts complex pleiotropic effects, primarily mediated through inhibition of monoamine reuptake and robust activation of the sympathetic nervous system, culminating in both systemic and tissue-specific sequelae [1]. Central to its pathogenicity is intense vasoconstriction, which underlies many of its ischemic and vasculopathic complications [1]. Currently, cocaine is used illicitly, most commonly through intranasal insufflation or inhalation, and has re-emerged as a significant and escalating public health concern in the United Kingdom and across Europe [2, 3]. The latest surveillance data from the Office for National Statistics indicate that approximately 3% of adults aged 16–59 years in the UK report on cocaine use, with a disproportionately high prevalence among young adults aged 16–24 years [3]. As cocaine use continues to rise, and as the drug is increasingly adulterated with various substances that may potentiate or modify its properties, most notably levamisole, an expanding spectrum of atypical clinical presentations are recognized across multiple systems, including the head and neck mucosal and skin surfaces [4]. Classically, most cocaine-related manifestations are attributed to direct cytotoxic effect on local tissues, but it is now understood that others are part of a broader, systemic response to cocaine exposure simulating autoimmune vasculitides with presence of circulating autoantibodies (cocaine and levamisole-induced vasculitis or cocaine-induced pseudo-granulomatosis with polyangiitis-GPA) [4, 5]. Such immunologic activation may coexist with a diverse range of topical mucosal and cutaneous manifestations, spanning necrotic mucosal lesions (cocaine-induced midline destructive lesions-CIMDL), eczema-like eruptions, neutrophilic dermatoses, and prurigo-like lesions. More recently, a distinct clinicopathological entity has been described in cocaine users who do not commonly show serological or histological evidence of vasculitis or neutrophilic disorder, coined as Cocaine-induced plasma cell dermatomucositis/orificial mucositis (CI-PCDM) [6, 7]. This condition characteristically involves the periorificial region of the upper lip extending to the nasal philtrum and nostrils. Clinically, it presents as a progressively enlarging, exophytic, and partially ulcerated plaque, with features that may closely mimic malignancy [6, 7]. As its name suggests, it is characterized microscopically by a dense, polyclonal plasma-cell–rich infiltrate, often accompanied by variable eosinophilia [6, 7]. In this case series, we report six new cases of cocaine-induced plasma cell dermatomucositis, highlighting their clinical presentation and histopathological features aiming to increase awareness of this rather underreported entity. Materials and Methods This retrospective, multi-center case series identified patients diagnosed with CI-PCDM through a search of the authors’ (N.K. and P.T.) pathology archives and clinical databases. Clinical data, demographics, further investigations, treatment and follow-up where available were retrieved from electronic records and medical photography. Histopathology reports were reviewed to confirm the diagnostic features and the exclusion of other etiologies. The study adhered to the 1964 Declaration of Helsinki and complied with the UK Data Protection Act and GDPR and NHS Research Ethics Committee (REC) guidelines. Written informed consent was obtained from three patients for the use of clinical photography; all other data were anonymized to protect patient confidentiality. Results A total of six cases were retrieved (Table 1). There was a male predominance (5 males, 1 female) with a mean age of 50.3 years. The most frequent clinical presentation was a variously nodular, exophytic mass associated with ulceration and crusting (Fig. 1a, b) with a mean duration of 7 months. In five of the six cases, the upper lip and nostrils were simultaneously affected; two of these patients also presented with septal perforation. Imaging performed did not demonstrate sinus involvement or other destructive lesions. Table 1Relevant clinicopathological details of the CI-PCDM cohortAge/SexClinical presentationAffected sitesNo of biopsies prior to diagnosisDurationHistopathologicalexaminationFurther investigationsTreatmentOutcomeMedical history49/MLarge, ulcerative exophytic mass with bleedingupper lip,tip of nose412 monthsPolyclonal dense plasma-cell infiltrates admixed with eosinophilsNegative fungal, viral and bacterial stainsIgG4/IgG < 40%IgG4 +,Anti-PR3+(c-ANCA)Urine analysis (+) for cocaine and cannabisSurgical debulkingPartial resolutionpsoriasiscocaine use (stopped 1 year ago)43/MLaceration and septal perforationupper lip,nostrils,septumN/AN/APolyclonal dense plasma-cell aggregates admixed with eosinophils, and histiocytesNegative fungal, viral and bacterial stainsIgG4/IgG > 40%Negative serological testsStaphylococcus aureus (+)N/ALost to follow-upcannabis usesuspected cocaine use47/MUlcerated, nodular massLymphadenopathyupper lip,nostrils13 monthsPerivascular and perifollicular dense polyclonal plasma-cell infiltrates with numerous eosinophilsNegative fungal, viral and bacterial stainsIgG4/IgG < 40%Negative serological testsPrednisoneCocaine cessationPartial resolutionJAK2 (-) erythrocytosisDaily cocaine use49/MErythematous massupper lip,left nostril26 monthsPerivascular and perifollicular dense, polyclonal plasma-cell infiltrates,Negative fungal, viral and bacterial stainsIgG4/IgG < 40%Anti-PR3+(c-ANCA)Decreased renal functionPrednisoloneCocaine cessationPartial resolution(residual scar)Daily cocaine use51/FUlcerated nodular mass with necrotic surfaceSeptal perforationRight upper lip,right nostril,septumN/A5 monthsPsoriasiform acanthosis and spongiosisPerivascular plasma-cell and lymphocytic infiltrationsNegative fungal, viral and bacterial stainsIgG4/IgG < 40%Negative serological testsIncreased kappa/lambda on bloodUrine analysis (+) for cocaineN/AN/ACrohn’s disease under adalimumabAutoimmune gastritisChronic opiate use63/MUlcerated plaqueNasal philtrum, columella, nasal vestibule (including alar cartilages)septum19 monthsPolyclonal dense plasma-cell infiltrates admixed with eosinophilsNegative fungal, viral and bacterial stainsIgG4/IgG < 40%Negative serological testsCocaine cessationTopical nasal emollientsUnder surveillanceCocaine useM, male, F, female, N/A, not available Relevant clinicopathological details of the CI-PCDM cohort upper lip, tip of nose Polyclonal dense plasma-cell infiltrates admixed with eosinophils Negative fungal, viral and bacterial stains IgG4/IgG < 40% IgG4 +, Anti-PR3+ (c-ANCA) Urine analysis (+) for cocaine and cannabis psoriasis cocaine use (stopped 1 year ago) upper lip, nostrils, septum Polyclonal dense plasma-cell aggregates admixed with eosinophils, and histiocytes Negative fungal, viral and bacterial stains IgG4/IgG > 40% Negative serological tests Staphylococcus aureus (+) cannabis use suspected cocaine use Ulcerated, nodular mass Lymphadenopathy upper lip, nostrils Perivascular and perifollicular dense polyclonal plasma-cell infiltrates with numerous eosinophils Negative fungal, viral and bacterial stains IgG4/IgG < 40% Prednisone Cocaine cessation JAK2 (-) erythrocytosis Daily cocaine use upper lip, left nostril Perivascular and perifollicular dense, polyclonal plasma-cell infiltrates, Negative fungal, viral and bacterial stains IgG4/IgG < 40% Anti-PR3+ (c-ANCA) Decreased renal function Prednisolone Cocaine cessation Partial resolution (residual scar) Ulcerated nodular mass with necrotic surface Septal perforation Right upper lip, right nostril, septum Psoriasiform acanthosis and spongiosis Perivascular plasma-cell and lymphocytic infiltrations Negative fungal, viral and bacterial stains IgG4/IgG < 40% Negative serological tests Increased kappa/lambda on blood Urine analysis (+) for cocaine Crohn’s disease under adalimumab Autoimmune gastritis Chronic opiate use Nasal philtrum, columella, nasal vestibule (including alar cartilages) septum Polyclonal dense plasma-cell infiltrates admixed with eosinophils Negative fungal, viral and bacterial stains IgG4/IgG < 40% Cocaine cessation Topical nasal emollients M, male, F, female, N/A, not available a–d: Representative clinical images of CI-PCDM: Variously ulcerated, exophytic plaques affecting the nasolabial region (a-Case 1, b-Case 4). Follow-up images of Case 1 after surgical debulking (c) and Case 4 following management with systemic steroids and cocaine cessation (d) indicate partial improvement Illicit drug use was reported in all cases. While four patients admitted to cocaine use, two initially denied it; however, one of the latter subsequently tested positive for cocaine via urinalysis. In two cases, multiple biopsies were performed before reaching a final diagnosis. On histopathology, all cases demonstrated a dense plasma cell infiltrate within the dermis, typically in perivascular and periadnexal distributions (Fig. 2a–d). No evidence of vasculitis or granuloma formation was observed. In 50% of the cases, a significant number of eosinophils were noted within the plasmacytic infiltrates. Viral, fungal, and bacterial stains were negative across all cases. Immunohistochemical analysis for kappa and lambda light chains confirmed the polyclonality of the plasma cells; in one case, an increased IgG4:IgG ratio was identified (Fig. 3a–e). Representative histopathological images of CI-PCDM: (a) exophytic, partly ulcerated plaque showing dense, deep seated plasma-cell infiltrates. (b) Diffuse positivity for plasma cell marker CD138 (c) There are numerous plasma cells admixed with eosinophils arranged in perivascular and periadnexal distribution. (d) No evidence of necrosis or vasculitis is seen Representative immunohistochemistry images of CI-PCDM: One case showed increased IgG4:IgG ratio; hematoxylin and eosin (a), IgG4 (b) and IgG (c) (original magnification: 10x), Staining for kappa (d) and lambda (e) light chains revealed a polyclonal plasma-cell population All patients underwent serological screening for autoimmune vasculitides. Two patients tested positive for c-ANCA (anti-Proteinase 3-PR3), while no other autoantibodies were detected. Interestingly, one of the seropositive patients subsequently developed a decline in renal function and is currently undergoing investigation for systemic involvement. Regarding IgG4 expression, one patient exhibited an increased serum IgG4:IgG ratio without a corresponding increase in the examined tissue. Another patient demonstrated elevated serum levels of both kappa and lambda light chains, though the ratio remained normal. In cases where treatment and follow-up data were available, two patients were managed with systemic corticosteroids and one underwent surgical debulking. All patients showed partial clinical improvement, though complete resolution of the lesions was not achieved (Fig. 1c, d). Discussion This is the first case series of CI-PCDM in the UK. To date, only 17 cases (excluding ours) have been reported in the literature; 13 cases have originated from Spanish institutions and 4 cases from the U.S (Table 2) [6–11]. The mean age and gender profile of our cohort are consistent with the existing literature, as are the clinical presentations, affected sites, and histopathological findings. Table 2Review of all CI-PCDM cases published in the literatureReferencesAge/sexClinical presentationAffected sitesDurationHistopathologyFurther investigationsTreatmentOutcomeComment Udondo González del Tánago et al. [8]60/MExudative ulcerated lesionUpper lip,Left nasal vestibule1 monthNumerous eosinophils with few eosinophilsNegative fungal, viral, bacterial stainsN/A30 mg of prednisoneResolutionOriginally termed “cocaine-induced plasma cell orificial mucositis” Viedma-Martinez et al. [6]45.5 (mean), 6 males, 4 femalesPseudo-tumoral ulcerated plaqueUpper lip,Nostrils9 months (mean)Dense plasmacell infiltrate with eosinophilsNegative fungal, viral, bacterial stainsc-ANCA (+),(2 cases)↑ eosinophils(5 cases)Topical and systemic steroidsResolution(6 cases)Relapse(1 case)Originally termed “cocaine-induced plasma cell orificial mucositis” Fernandez-Flores et al. [7]56/MProgressive thickened plaqueUpper lipNostril12 monthsNeutrophilic infiltrate in upper dermisDeeper plasma-cell infiltrates with eosinophilsNegative fungal, viral, bacterial stainsNegative serological testsN/AN/AProposed the term “cocaine-induced plasma cell dermatomucositis” Reyes Albaladejo et al. [9]40/FExudative plaqueSupralabial region, nasal vestibule and distal nasal tip3 monthsDense lymphoplasmacytic infiltrateIG4:IGG > 40%Negative fungal, viral, bacterial stains↑ neutrophils, ↑ eosinophils, c-ANCA (+)45 mg of prednisoneResolution Tordjman et al. [10]66/MUlcerated plaqueRight nasolabial region7 monthsDense plasma-cell infiltrate with eosinophilsS.Aureus and P.Aeruginosa (+)Negative serological testsPrednisoneRecurrence upon tapering Patel Housley et al. [11]53.6(mean)2 males, 1 femaleVegetative plaquesUpper lip,nasolabial folds2 months (mean)Dense plasma-cell infiltrate with eosinophilsc-ANCA (+) all casesRituximab(1 case)Systemic steroids(1 case)Resolution (2 cases)Uses the term “cocaine-induced plasma cell orificial mucositis Our case series 50.3 (mean)5 males, 1 femaleUclerated plaqueSeptal perforation(2 cases)Upper lip, nostrils(all cases)Septum(2 cases)4.8 months (mean)Dense plasma-cell infiltrate with eosinophilsNegative fungal, viral, bacterial stainsS.Aureus (+) (one case)IgG4:IgG ~ 60% (one case)c-ANCA (+) (2 cases), IgG4 ↑ (one case)kappa, lambda ↑ (one case)Surgical debulking(1 case)Predinisolone(2 cases)Topical nasal emollients(1 case)Partial resolution(3 cases) Summary:45.5(Viedma-Martinez et al.2024)*52.7(rest of cases)Variably ulcerated plaque/lesion (23 cases)Septal perforation(3 cases)Upper lip and nasal cavity (23 cases)Septum (3 cases)5.6 months(mean; all cases)Deeper plasma-cell infiltrates (23/23)IG4:IGG > 40% (2/20)S.Aureus and P.Aeruginosa (+) (2 cases)c-ANCA (+) (8/23)↑ eosinophils(3 cases)Kappa, lambda ↑(one case)IgG4 ↑(one case)Systemic and topical steroid treatmentSurgical debulkingTopical nasal emollientsVariable results*Does not state exact age of patientsM, male, F, female, N/A, not available Review of all CI-PCDM cases published in the literature Udondo González del Tánago et al. [8] Upper lip, Left nasal vestibule Numerous eosinophils with few eosinophils Negative fungal, viral, bacterial stains Viedma-Martinez et al. [6] Upper lip, Nostrils Dense plasmacell infiltrate with eosinophils Negative fungal, viral, bacterial stains c-ANCA (+), (2 cases) ↑ eosinophils (5 cases) Resolution (6 cases) Relapse (1 case) Fernandez-Flores et al. [7] Upper lip Nostril Neutrophilic infiltrate in upper dermis Deeper plasma-cell infiltrates with eosinophils Negative fungal, viral, bacterial stains Reyes Albaladejo et al. [9] Dense lymphoplasmacytic infiltrate IG4:IGG > 40% Negative fungal, viral, bacterial stains Tordjman et al. [10] Dense plasma-cell infiltrate with eosinophils S.Aureus and P.Aeruginosa (+) 53.6(mean) 2 males, 1 female Rituximab (1 case) Systemic steroids (1 case) 50.3 (mean) 5 males, 1 female Uclerated plaque Septal perforation (2 cases) Upper lip, nostrils (all cases) Septum (2 cases) Dense plasma-cell infiltrate with eosinophils Negative fungal, viral, bacterial stains S.Aureus (+) (one case) IgG4:IgG ~ 60% (one case) c-ANCA (+) (2 cases), IgG4 ↑ (one case) kappa, lambda ↑ (one case) Surgical debulking (1 case) Predinisolone (2 cases) Topical nasal emollients (1 case) Partial resolution (3 cases) 45.5 (Viedma-Martinez et al.2024)* 52.7 (rest of cases) Variably ulcerated plaque/lesion (23 cases) Septal perforation (3 cases) Upper lip and nasal cavity (23 cases) Septum (3 cases) 5.6 months (mean; all cases) Deeper plasma-cell infiltrates (23/23) IG4:IGG > 40% (2/20) S.Aureus and P.Aeruginosa (+) (2 cases) c-ANCA (+) (8/23) ↑ eosinophils (3 cases) Kappa, lambda ↑ (one case) IgG4 ↑ (one case) Systemic and topical steroid treatment Surgical debulking Topical nasal emollients *Does not state exact age of patients M, male, F, female, N/A, not available While it is tempting to call CI-PCDM rare, given the scarcity of published cases, we believe that it probably represents an underreported and underdiagnosed rather than rare entity. This may be because similar nasolabial lesions were not initially biopsied and were “lumped” under the general descriptive term “cocaine-induced midline necrotic lesions-CIMDL”, especially when there was concurrent septal collapse, palatal perforation or other necrotizing mucosal or cutaneous lesions [4]. Additionally, even when biopsy is performed, histopathological features can be non-specific if the deeper dermis is not included in the specimen or may be overlooked by pathologists unfamiliar with CI-PCDM. Moreover, an initial biopsy showing non-specific findings is not an uncommon phenomenon in cocaine-induced disorders such as CIMDL, necessitating multiple biopsies, and careful clinicopathological correlation [12]. Notably, in two of our cases multiple biopsies of the lesions were performed previously before a final diagnosis of CI-PCDM was made, most of them reported as “non-specific inflammation”. Most patients in our cohort reported frequent cocaine use. One exception was a patient who was a habitual cannabis user but denied using cocaine; another patient, who had a history of using various opiates, tested positive for cocaine on urine analysis disproving their initial statement of abstaining from cocaine use. These instances underscore that confirmatory test for cocaine use, including urinalysis, should be performed in patients presenting with ulcerative nodular lesions in the nasolabial area, particularly when other illicit drug use is reported. A similar approach has been suggested for patients with midline destructive lesions and serological positivity for ANCA to confirm cocaine-induced pseudovasculitis and exclude other autoimmune vasculitides [13]. Interestingly, positivity for cANCA was seen in 6 out of the 17 published cases while 2 cANCA positive cases were found in our cohort. Anti-neutrophil cytoplasmic antibody (ANCA) positivity is reported in up to 70% of CIMDL cases [14]. However, no difference in clinical, serological or histopathological findings between ANCA-positive and ANCA-negative cocaine users that presented with CIMDL was found [14]. The presence of c-ANCA or p-ANCA positivity, paired with septal perforation or necrosis, is a feature also seen in two of our cases, raising the question of whether CI-PCDM belongs to the clinical spectrum of CIMDL and/or cocaine-induced pseudo-GPA [5, 12]. We argue that CI-PCDM is a distinct entity due to its clinical presentation as an isolated, ulcerated tumefactive plaque , likely at the site of cocaine contact, as opposed to the generalized necrotic lesions distant from the nasolabial area seen in CIMDL [5, 12]. Histologically, CI-PCDM is characterized by a predominance of plasma cells and eosinophils without evidence of vasculitis or tissue necrosis. While plasma cells can be found in CIMDL, they are rarely a prominent feature [5, 13]. Nevertheless, the possibility that CI-PCDM is a precursor to, or a subset of, the CIMDL spectrum cannot be entirely excluded given the limited number of reported cases and follow-up data. The most common cocaine adulterant worldwide, levamisole, exacerbates cocaine-induced tissue destruction by promoting neutrophilic elastase secretion thus inducing neutrophilic infiltration of tissues leading to vasculitis/necrosis and further influencing the ANCA positivity seen in these patients [15]. It remains unclear whether the seropositive patients in our cohort or the literature used cocaine adulterated with levamisole. Notably, in most of our cases, neutrophilic infiltration was not a prominent feature, unlike other levamisole-induced skin lesions [4]. Based on affected site and the histological presence of plasma-cell infiltrates, it is not surprising that CI-PCDM was initially linked to plasma cell mucositis (PCM) or idiopathic lymphoplasmacellular mucositis-dermatitis, the mucosal-cutaneous analogue of Zoon’s balanitis [16, 17]. However, this entity shows primarily mucosal involvement appearing as erythema or cobblestone-like lesions of the gingiva and inner labial mucosa and rarely extends “upwards” to the skin of nostrils [16]. Its exact causes are unknown but is thought to represent a hypersensitivity reaction to an intraoral irritant, such as chewing gum or toothpaste [16]. The histology is strikingly similar to CI-PCDM while some PCM cases have also shown positivity for circulating autoantibodies. Since many of the clinicopathological findings of PCM are identical to CI-PCDM, one might wonder if CI-PCDM is the cutaneous counterpart of PCM, potentially triggered by a cutting agent other than levamisole acting as a local irritant as other authors have previously suggested [6]. Another commonly reported adulterant of cocaine, especially in the UK, is benzocaine, a topical ester anesthetic used to enhance the numbing sensation associated with cocaine [18]. Benzocaine-associated allergic contact dermatitis, contact stomatitis, and other mucosal hypersensitivity reactions are well described [19–21]. In addition, plasma-cell-rich inflammatory infiltrates have been reported in chronic contact hypersensitivity reactions and mucosal inflammatory disorders [22]. In this context, the marked plasmacytosis observed in CI-PCDM may suggest a chronic, antigen-driven immune response distinct from the acute neutrophilic-mediated tissue destruction typical of classic cocaine-induced necrosis. This process may reflect a localized cytokine milieu enriched in Interleukin-6 (IL-6), a cytokine known to promote B-cell differentiation into mature plasma cells [23]. Experimental and clinical studies of contact hypersensitivity reactions have further demonstrated the involvement of IL-6 and related pro-inflammatory cytokines in allergen-driven mucocutaneous inflammation [24]. Repeated intranasal exposure to cocaine adulterated with benzocaine could therefore plausibly act as a persistent local haptenic stimulus, triggering chronic mucosal hypersensitivity and contributing to the plasma-cell-rich inflammatory pattern observed in CI-PCDM [6, 16, 19–25]. Nevertheless, the precise adulterants involved remain uncertain, as specific adulterant analyses were not available in our cohort and have not been systematically reported in previously published cases. An increased IgG4:IgG ratio in tissue or serum was observed in two of our cases, consistent with other published reports. Reyes Albaladejo et al. [9] postulated that an increased IgG4 ratio can be part of the CI-PCDM spectrum, particularly in the absence of other features of IgG4-related disease (IgG4-RD). The 2020 revised criteria for IgG4-RD combine clinical findings, most commonly internal organ involvement, with serological evidence of IgG4 overexpression (> 135 mg/dl) and specific histological features i.e. storiform fibrosis, obliterative phlebitis and IgG4: IgG ratio of over 40% [26]. While some of the criteria were met in the two previously mentioned cases, they did not qualify for a definitive IgG4-RD diagnosis. Furthermore, increased IgG4 + plasma cells are seen in many other conditions, including autoimmune vasculitides, especially when affecting the head and neck [27]. Interestingly, one patient had an increased tissue IgG4:IgG ratio despite normal serum levels, while another with elevated serum IgG4 did not show an abnormal ratio in the excised tissue, suggesting a discrepancy between systemic and localized IgG4 expression. Given that increased IgG4-positive plasma cells may occur in a variety of chronic inflammatory and autoimmune conditions and are not specific for IgG4-related disease, it is possible that the IgG4 overexpression observed in a subset of CI-PCDM cases reflects a secondary immune response to chronic antigenic stimulation/chronic inflammation rather than true IgG4-related disease, as various authors have suggested [27, 28]. The differential diagnoses of plasma-cell rich tumefactive plaques in the upper lip and nasolabial skin include a wide range of entities. The polyclonal character and non-atypical appearance of the dense plasma-cell infiltrates rule out extramedullary involvement by plasma cell lymphoproliferative disorders [29]. Exclusion of primary or secondary syphilis is the first step of the diagnostic process and can be easily done by performing relevant histochemical and immunohistochemical stains [30]. Other infections, such as tuberculosis, rhinoscleroma, blastomycosis, or mucocutaneous leishmaniasis, that might affect the nasolabial region in the form of exudative, variously ulcerated plaques, can be excluded histologically by the absence of granuloma formation or bacteria-filled histiocytes, and negative PAS or Grocott-Gomorri stains [31]. One of our cases tested positive for Staphylococcus aureus, likely representing secondary colonization rather than primary infection, as typical signs like suppuration were absent. From a clinical perspective, CI-PCDM can mimic basal cell carcinoma and squamous cell carcinoma, necessitating urgent biopsy. Indeed, most basal cell carcinomas of the head and neck skin develop in the nose and in more advanced stages they can appear as ulcerative nodular plaques with indurated borders and local tissue destruction (“rodent’s ulcer”), identical to the lesions seen in our patients [32]. Thus, it is prudent to exclude malignancy by histopathological examination even in cases where CI-PCDM is strongly suspected clinically. Treatment in the literature often involves corticosteroids or immunomodulatory agents, with conflicting results and high recurrence rates [6]. In our cohort, two patients received systemic prednisolone, one was treated symptomatically with nasal emollients, and one underwent surgical debulking. Steroids and surgery provided a partial response, mostly aiding in decrease of the lesions’ size with or without residual scar, but complete resolution of the lesions was not seen. Response to treatment can also be hindered by maintenance of cocaine use during this time, highlighting the necessity of a multidisciplinary approach, including addiction specialists, to achieve long-term remission. Surgical debulking of CI-PCDM lesions has not been previously reported in the literature. The rationale behind such management in one of our cases was guided by both diagnostic uncertainty and disease burden. Given the extensive lesion size and inconclusive initial biopsy findings, a more comprehensive tissue sample was required to exclude malignancy before initiating any form of immunomodulatory therapy. This was also influenced by the need for anatomical structure preservation in a cosmetically sensitive area such as the nasolabial fold as well as for alleviation of symptoms with regression of the residual inflammatory process. This study is limited by its retrospective nature and the relatively small number of cases, reflecting the rarity and likely underrecognition of CI-PCDM. In addition, clinical follow-up and ancillary investigations were not uniformly available across all patients due to differences in institutional work-up pathways and tissue availability. In summary, this two-center case series aims to increase awareness among clinicians and pathologists of this emerging entity when evaluating ulcerated nodular lesions affecting the nasolabial region in patients with a history of cocaine use. Greater recognition and reporting of such cases will facilitate a deeper understanding of its pathogenesis and help define optimal management strategies. Author Contributions G.T. performed data collection, conceptualization, literature review, figure preparation nd wrote the main manuscript text, N.K. and P.T. contributed cases and participated in conceptualization of the study, E.M., L.C., W.G., K.P., C.B., A.T., and T.T. contributed clinical cases, patient management and multidisciplinary assessment, and obtained patient consent for clinical photography. All authors reviewed and approved the final manuscript. Data Availability No datasets were generated or analysed during the current study. Declarations Conflict of interest The authors declare having no commercial or personal associations, current and past, that might pose a potential, perceived or real conflict of interest. Ethical Approval In accordance with institutional guidelines, formal ethical review is not required for this retrospective case series. Consent for Participation and Publication The authors affirm that human research participants provided informed consent for publication of the images in Fig. 1. The other images only contain pathology slides, for which it is not necessary to obtain consent. To protect patient confidentiality, all other potentially identifiable data have been removed, and all remaining cases were fully anonymized in compliance with 1964 Declaration of Helsinki, GDPR and the UK Data Protection Act and NHS Research Ethics Committee (REC) guidelines. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement No datasets were generated or analysed during the current study.